PCVX ▲ +0.7% - Vaxcyte, Inc.
$PCVX - Vaxcyte to Host Webcast and Conference Call to Present Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
04-OCT-2026 05:00 PM ET
Share this post
More filings for $PCVX
PCVX ▲ +9.4% - Vaxcyte, Inc.Oct 10, 2026PCVX ▼ -0.9% - Vaxcyte, Inc.Oct 7, 2026PCVX ▼ -9.8% - Vaxcyte, Inc.Oct 7, 2026PCVX ▲ +27.3% - Vaxcyte, Inc.Oct 5, 2026PCVX ▲ +10.4% - Vaxcyte, Inc.Oct 5, 2026PCVX ▼ -1.9% - Vaxcyte, Inc.Sep 3, 2026
View full $PCVX filing history →💬 Comments
Loading comments…
Leave a comment